Ibox global trial#
The CIBIL “ Clinical Impact of the i Box as an Early Intervention too L” trial is a prospective randomized controlled trial being conducted internationally with 450 patients to evaluate the clinical and health economic benefits of using iBox to predict allograft survival in the follow-up of kidney transplanted patients (NCT05112315). (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that its strategic partner, Cibiltech, a French MedTech company that develops artificial intelligence-based products for predictive medicine, has initiated the CIBIL clinical trial to evaluate the performance of iBox artificial intelligence (AI) as a prognostic measure of organ survival in kidney transplant patients. The uniqueness of a "complete-supply-chain" online service thus ensures a 100% sell-through rate.SOUTH SAN FRANCISCO, Calif., Ma(GLOBE NEWSWIRE) - CareDx, Inc. Moreover, the Company integrates its business with the dedicated placement on main marketplaces worldwide, ensuring the online management of both new collections and inventories stock. Thanks to its remarkable expertise, Giglio Group accompanies its customers in the online distribution of their products through a unique platform, starting from the implementation of fully tailor-made and managed monobrand e-store. The Company is based in Milan, but it is also present with offices in New York, Rome, Lugano and Genoa. Today's news fall in line with our already announced development project: indeed, Giglio Group has been investing for over a year in the new digital and e-commerce frontiers and, now that they have become a reality, we are the firsts to reap the benefits of this sector, with great expectations for the even more important developments of this new, high-potential business unit."įounded by Alessandro Giglio in 2003 and listed on the STAR segment of Borsa Italiana ever since 2018, Giglio Group is the leading company for the design, creation and management of high value-added e- commerce platforms in Italy for Fashion, Design, Lifestyle and, more recently, Food and Healthcare sectors. More specifically, the services ensured by Giglio Group shall cover the wider range of e-commerce services, from the creation, activation and development of the e-store to international logistics, from store and brand management to customer care and website management (graphic design, promotion and marketing automation).Īlessandro Giglio, Chairman and CEO of Giglio Group, declared: "Cooperating with one of the greatest rock bands in the world is a source of great pride and satisfaction for both our Group and our team, which have been working for months on end in order to finalise this amazing project.
The agreement provides for the development and management of the e-store well as for the production of the band's merchandising. (Ticker GG), through its subsidiary IBOX SA, signed an important three-year agreement with Måneskin Empire, the exclusive owner of the image rights of the namesake international iconic rock band, Måneskin, boasting 3 billion streaming views, as well as gold and platinum records collected all around the world. Milan, 18 March 2022 - Yesterday Giglio Group S.p.A., an e-commerce and NFT company listed on the STAR-Euronext Milan segment of Borsa Italiana S.p.A. TO GIGLIO GROUP S.P.A., ON A GLOBAL SCALE SALES AND PRODUCTION OF THEIR MERCHANDISING THE ROCK BAND MÅNESKIN ENTRUSTS THE ONLINE